Skip to main content

Biopharma

Connexius Biologics SEA 2028

Date
24–25 October 2028
Location
Ho Chi Minh City, Vietnam

Event details coming soon

The programme, speakers and registration details for this conference are being finalised. Register your interest and we will send them through as soon as they are confirmed.

Register your interest

INSIGHTS

  • BiopharmaMarket insight

    Why Singapore Is Emerging as Biopharma’s China+1 Hub

    Singapore’s biopharmaceutical sector is navigating short-term production volatility while strengthening its long-term position as a trusted bridge between China and Western markets. This article examines how Singapore’s regulatory credibility, advanced manufacturing ecosystem and geopolitical neutrality support its emerging role as a China+1 hub for global biopharma.

    Read more: Why Singapore Is Emerging as Biopharma’s China+1 Hub
  • BiopharmaMarket insight

    Asia’s Biopharma Manufacturing Landscape Is Changing. Where Are the New Hubs Emerging?

    Asia’s biopharmaceutical manufacturing landscape is evolving into a network of specialised ecosystems rather than a single regional hub. This article examines how South Korea, Singapore, China, India, Japan and emerging Southeast Asian markets are developing distinct roles across biologics, advanced therapies and vaccine production.

    Read more: Asia’s Biopharma Manufacturing Landscape Is Changing. Where Are the New Hubs Emerging?
  • BiopharmaIndustry article

    Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia

    On 12 November 2026, Eppendorf SE broke ground on a new production facility at Bandar Cassia Technology Park in Penang. The EUR 40 million investment is the company's first manufacturing operation in Southeast Asia and will produce selected products from its Centrifuges & Instruments portfolio for laboratories worldwide, with production starting gradually in 2028.

    Read more: Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia